Docshil 80mg Injection

Salt Composition: Docetaxel  
Manufacturer: SHILPA MEDICARE LTD  
0 0 4
Out of Stock
   Check delivery options  
 
Share: 

About

Docetaxel is a prominent taxane antineoplastic agent extensively used in the management of various advanced cancers. Its mechanism of action involves binding to tubulin, promoting the assembly of stable microtubules from tubulin dimers, and simultaneously inhibiting their depolymerization. This stabilization prevents the normal dynamic reorganization of the microtubule network, which is absolutely essential for critical cellular functions during interphase and, most notably, during mitosis. The disruption of microtubule dynamics leads to mitotic arrest, where cancer cells are unable to complete division, ultimately triggering programmed cell death (apoptosis). This potent anti-tumor activity makes docetaxel highly effective against a spectrum of solid tumors, including metastatic breast cancer, non-small cell lung cancer, hormone-refractory prostate cancer, and advanced gastric adenocarcinoma. Its administration often requires careful patient selection and monitoring for potential side effects, including hypersensitivity reactions and myelosuppression.

Uses

  • Treatment of breast cancer.
  • Management of non-small cell lung cancer.
  • Used in prostate cancer.
  • Treatment of gastric adenocarcinoma.

Directions For Use

Administered intravenously by a healthcare professional, typically over one hour. Premedication is often required to reduce hypersensitivity reactions.

Benefits

  • Effective against a broad range of solid tumors.
  • Induces mitotic arrest and apoptosis in cancer cells.
  • Can be used in metastatic and adjuvant settings.
  • Often part of combination chemotherapy regimens.
  • Well-established efficacy in oncology.
  • Improves progression-free and overall survival in certain cancers.

Side Effects

  • Myelosuppression (neutropenia)
  • Fluid retention (edema)
  • Hypersensitivity reactions
  • Peripheral neuropathy
  • Nausea and vomiting
  • Alopecia (hair loss)
  • Fatigue/asthenia
  • Mucositis
  • Diarrhea
  • Nail changes
  • Skin reactions
  • Muscle and joint pain

Safety Measures

  • Alcohol - Docetaxel formulations often contain alcohol (ethanol). Patients should be advised about the alcohol content and potential interactions, especially if they have alcohol intolerance or liver issues.
  • Pregnancy - Docetaxel is teratogenic and can cause fetal harm. It is contraindicated in pregnancy, and women of childbearing potential must use effective contraception during and for a period after treatment.
  • Breastfeeding - Breastfeeding is contraindicated during docetaxel therapy as the drug may be excreted in breast milk and could cause serious adverse effects in the nursing infant.
  • Liver - Use with caution and dose reduction is necessary in patients with hepatic impairment due to increased risk of severe adverse reactions, including myelosuppression and neurotoxicity.
  • Kidney - No specific dose adjustments are generally required for renal impairment, but caution is advised, and monitoring is recommended, especially in severe cases.
  • Lung - Rare but serious interstitial lung disease or pneumonitis can occur. Patients should be monitored for new or worsening pulmonary symptoms, and treatment may need to be interrupted.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.

Shipping Cost
Shop Location Assam, India

No comments found for this product. Be the first to comment!